OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex biologics. Optimizing these processes involves fine-tuning various parameters, including cell line selection, media formulation, and bioreactor settings. A key goal is to maximize antibody yield while lowering production financial